| Q57812902 | A Self-Managed System for Automated Assessment of UPDRS Upper Limb Tasks in Parkinson's Disease |
| Q63952464 | A Simplified Version of the Psychogenic Movement Disorders Rating Scale: The Simplified Functional Movement Disorders Rating Scale (S-FMDRS) |
| Q81554340 | A definition of "on": patient diaries compared to the UPDRS |
| Q37062838 | A review of disease progression models of Parkinson's disease and applications in clinical trials |
| Q35479549 | A short scale for the assessment of motor impairments and disabilities in Parkinson's disease: the SPES/SCOPA |
| Q50262212 | Acute effects of passive leg cycling on upper extremity tremor and bradykinesia in Parkinson's disease |
| Q91096765 | An Integrated Multi-Sensor Approach for the Remote Monitoring of Parkinson's Disease |
| Q37863587 | An update on gene therapy in Parkinson's disease |
| Q35123605 | Association between essential tremor and other neurodegenerative diseases: what is the epidemiological evidence? |
| Q41524729 | Automated motion sensor quantification of gait and lower extremity bradykinesia |
| Q34185526 | Blood oxygenation level-dependent activation in basal ganglia nuclei relates to specific symptoms in de novo Parkinson's disease |
| Q38368117 | Can Baropodometric Analysis be a Useful Tool in the Early Diagnosis of Atypical Parkinsonism? Preliminary Findings |
| Q36443271 | Can a screening questionnaire accurately identify mild Parkinsonian signs? |
| Q99238090 | Clinical and Oculomotor Correlates With Freezing of Gait in a Chinese Cohort of Parkinson's Disease Patients |
| Q48456869 | Clinical impairment of sequential finger movements in Parkinson's disease. |
| Q34120746 | Clinical observations after neural transplantation in Parkinson's disease |
| Q30771707 | Clinical significance of basal ganglia alterations at brain MRI and 1H MRS in cirrhosis and role in the pathogenesis of hepatic encephalopathy |
| Q48566146 | Cognitive and Neuropsychiatric Features of Early Parkinson's Disease |
| Q39117135 | Comparative analysis of speech impairment and upper limb motor dysfunction in Parkinson's disease. |
| Q37078913 | Comparison of clinical manifestations in Alzheimer disease and dementia with Lewy bodies |
| Q34813794 | Correlation between serum RANTES levels and the severity of Parkinson's disease |
| Q48935857 | Deep-brain stimulation in the subthalamic nuclei improves balance performance in patients with Parkinson's disease, when tested without anti-parkinsonian medication. |
| Q92863728 | Development of digital biomarkers for resting tremor and bradykinesia using a wrist-worn wearable device |
| Q73533013 | Discriminating mild parkinsonism: methods for epidemiological research |
| Q36018225 | Dynamic High-Cadence Cycling Improves Motor Symptoms in Parkinson's Disease |
| Q30459996 | Effect of deep brain stimulation on speech performance in Parkinson's disease |
| Q30471289 | Effects of subthalamic stimulation on speech of consecutive patients with Parkinson disease |
| Q33617809 | Evidence for the toxicity of bidirectional transcripts and mitochondrial dysfunction in blood associated with small CGG expansions in the FMR1 gene in patients with parkinsonism |
| Q35712599 | Familial aggregation of dementia with Lewy bodies |
| Q64065685 | Feasibility of Home-Based Automated Assessment of Postural Instability and Lower Limb Impairments in Parkinson's Disease |
| Q42610878 | Finger tapping movements of Parkinson's disease patients automatically rated using nonlinear delay differential equations. |
| Q48651369 | Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy. |
| Q61714363 | Gait quantitation in Parkinson's disease ? locomotor disability and correlation to clinical rating scales |
| Q55075777 | Identification of Human Limb Viscoelasticity using Robotics Methods to Support the Diagnosis of Neuromuscular Diseases |
| Q47905154 | Impact of medication therapy management in patients with Parkinson's disease |
| Q48858779 | Impairments of speed and amplitude of movement in Parkinson's disease: a pilot study. |
| Q44701012 | Lack of efficacy of a nicotine transdermal treatment on motor and cognitive deficits in Parkinson's disease |
| Q36525761 | Lessons learned in deep brain stimulation for movement and neuropsychiatric disorders. |
| Q35459081 | Long term outcome of unilateral pallidotomy: follow up of 15 patients for 3 years |
| Q48404345 | Long-term efficacy of thalamic deep brain stimulation for tremor: double-blind assessments |
| Q33548162 | Maternal inheritance and mitochondrial DNA variants in familial Parkinson's disease |
| Q90395448 | Measures of balance and falls risk prediction in people with Parkinson's disease: a systematic review of psychometric properties |
| Q37021406 | Methodology of clinical research in rare diseases: development of a research program in juvenile neuronal ceroid lipofuscinosis (JNCL) via creation of a patient registry and collaboration with patient advocates |
| Q37124402 | Mild cognitive impairment is associated with mild parkinsonian signs in a door-to-door study. |
| Q33246685 | Motor function in Parkinson's disease and supranuclear palsy: simultaneous factor analysis of a clinical scale in several populations |
| Q36903375 | Parkinson's disease rigidity: relation to brain connectivity and motor performance |
| Q73503025 | Parkinson's disease subtypes: clinical classification and ventricular cerebrospinal fluid analysis |
| Q40613522 | Prediction of outcome of physiotherapy in advanced Parkinson's disease |
| Q35069101 | Prevalence of wearing-off and dyskinesia among the patients with Parkinson's disease on levodopa therapy: a multi-center registry survey in mainland China |
| Q50677224 | Quantifying Parkinson's disease finger-tapping severity by extracting and synthesizing finger motion properties. |
| Q48254172 | Reassessment of unilateral pallidotomy in Parkinson's disease. A 2-year follow-up study |
| Q64090393 | Safety and preliminary efficacy of intranasal insulin for cognitive impairment in Parkinson disease and multiple system atrophy: A double-blinded placebo-controlled pilot study |
| Q37030864 | Salivary total α-synuclein, oligomeric α-synuclein and SNCA variants in Parkinson's disease patients |
| Q40292437 | Scales in Parkinson's disease |
| Q82029370 | Scales to measure parkinsonism |
| Q47566515 | Segmentation of Gait Sequences in Sensor-Based Movement Analysis: A Comparison of Methods in Parkinson's Disease |
| Q96608937 | Speech-based characterization of dopamine replacement therapy in people with Parkinson's disease |
| Q35785690 | Subject-investigator reproducibility of the Unified Parkinson's Disease Rating Scale |
| Q30477330 | Subthalamic nucleus deep brain stimulation changes speech respiratory and laryngeal control in Parkinson's disease |
| Q30476711 | Subthalamic nucleus deep brain stimulation changes velopharyngeal control in Parkinson's disease |
| Q34775648 | Subthalamic nucleus deep brain stimulation does not improve visuo-motor impairment in Parkinson's disease |
| Q44125040 | Test-retest reliability of the unified Parkinson's disease rating scale in patients with early Parkinson's disease: results from a multicenter clinical trial |
| Q61811697 | The Diagnostic Scope of Sensor-Based Gait Analysis in Atypical Parkinsonism: Further Observations |
| Q46789074 | The Parkinson-Control study: a 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease. |
| Q48017531 | The Predictors study: Development and baseline characteristics of the Predictors 3 cohort. |
| Q59329392 | The Spectrum of Neurological and White Matter Changes and Premutation Status Categories of Older Male Carriers of the Alleles Are Linked to Genetic (CGG and FMR1 mRNA) and Cellular Stress (AMPK) Markers |
| Q50884327 | The health burdens of Parkinson's disease. |
| Q33636346 | The occurrence of fatigue in independent and clinically stable filipino patients with idiopathic Parkinson's disease |
| Q46534724 | The relationships between the unified Parkinson's disease rating scale and lower extremity functional performance in persons with early-stage Parkinson's disease |
| Q53576655 | The usefulness of the Functional Status Questionnaire and Medical Outcomes Study Short Form in Parkinson's disease research. |
| Q34595203 | Unbiased and mobile gait analysis detects motor impairment in Parkinson's disease |
| Q33448120 | Validation of a Smartphone Application Measuring Motor Function in Parkinson's Disease |
| Q35772039 | Validation of an ambulatory capacity measure in Parkinson disease: a construct derived from the Unified Parkinson's Disease Rating Scale |
| Q90381059 | Wearable Sensors for Estimation of Parkinsonian Tremor Severity during Free Body Movements |
| Q42705320 | Wearable sensors objectively measure gait parameters in Parkinson's disease |